Read More Pharma Industry News Neurizon Therapeutics secures global licence from Elanco to fast-track NUZ-001 commercialisation Find out how Neurizon’s global licence with Elanco is accelerating ALS therapy NUZ-001 and de-risking its path to market entry and clinical trials. byPallavi MadhirajuJuly 7, 2025